Clinical Trial Update: Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma [Phase 2]

View source ↗

Summary

Phase II trial evaluating AZD4604 on airway inflammation and biomarkers in adults with asthma has completed. The snippet does not provide study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD4604

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED